Veterinary Medicines

Gonavet Veyx 50 µg/ml solution for injection for cattle, pigs and horses

Authorised
  • Gonadorelin (6-D-phenylalanine) acetate
Download as PDF

Product identification

Medicine name:
Gonavet Veyx 50 µg/ml solution for injection for cattle, pigs and horses
GONAVET VEYX
Active substance:
  • Gonadorelin (6-D-phenylalanine) acetate
Target species:
  • Cattle
  • Pig
  • Horse
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Gonadorelin (6-D-phenylalanine) acetate
    52.40
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)
  • (ID2) 20 millilitre(s): unspecified outer container with 1 Vial (Glass) with 20 millilitre(s)
  • (ID1) 10 millilitre(s): unspecified outer container with 1 Vial (Glass) with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104761
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0158/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/05/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."